Log in

NASDAQ:INNTInnovate Biopharmaceuticals News Headlines

$0.55
-0.03 (-5.18 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.53
Now: $0.55
$0.58
50-Day Range
$0.53
MA: $0.59
$0.67
52-Week Range
$0.37
Now: $0.55
$1.67
Volume1.82 million shs
Average Volume525,982 shs
Market Capitalization$22.69 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.39

Headlines

Innovate Biopharmaceuticals (NASDAQ INNT) News Headlines

Source:
DateHeadline
Oncology Nursing Society Announces Awardees of Nurses Innovate QuickFire Challenge in OncologyOncology Nursing Society Announces Awardees of Nurses Innovate QuickFire Challenge in Oncology
www.prnewswire.com - May 28 at 1:34 PM
Innovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® IndexesInnovate Biopharmaceuticals, Inc. added to membership of Russell 3000®, 2000® and the Russell Microcap® Indexes
www.bloomberg.com - May 18 at 7:36 PM
Merger brings new public company to Raleigh with $22 million to spendMerger brings new public company to Raleigh with $22 million to spend
www.bizjournals.com - May 1 at 5:45 PM
9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma
finance.yahoo.com - April 30 at 10:28 PM
New marketing manager joins Innovate Marquette SmartZone, Invent@NMUNew marketing manager joins Innovate Marquette SmartZone, [email protected]
www.msn.com - April 9 at 6:30 PM
Innovate Biopharmaceuticals, Inc: Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational UpdatesInnovate Biopharmaceuticals, Inc: Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational Updates
www.finanznachrichten.de - March 20 at 6:33 PM
Innovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational UpdatesInnovate Biopharmaceuticals Announces Full Year 2019 Financial Results And Strategic And Operational Updates
finance.yahoo.com - March 20 at 6:33 PM
Innovate Biopharmaceuticals Affirms Timeline for Closing of Merger with RDD Pharma Ltd. Closing Expected Around the End of the First Quarter of 2020Innovate Biopharmaceuticals Affirms Timeline for Closing of Merger with RDD Pharma Ltd. Closing Expected Around the End of the First Quarter of 2020
finance.yahoo.com - March 11 at 1:02 PM
Innovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate HighlightsInnovate Biopharmaceuticals Reports Second Quarter 2018 Earnings and Key Corporate Highlights
www.bloomberg.com - February 19 at 11:52 PM
Innovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the 2020 Digestive Disease Week (DDW) ConferenceInnovate Biopharmaceuticals Announces Acceptance of Three Abstracts for the 2020 Digestive Disease Week (DDW) Conference
finance.yahoo.com - February 19 at 8:52 AM
Innovate Biopharmaceuticals Announces Shareholder Approval of All Proposals in Connection with the Pending Merger with RDD Pharma Ltd. to Create 9 Meters Biopharma, a GI-focused Platform CompanyInnovate Biopharmaceuticals Announces Shareholder Approval of All Proposals in Connection with the Pending Merger with RDD Pharma Ltd. to Create 9 Meters Biopharma, a GI-focused Platform Company
finance.yahoo.com - February 18 at 8:05 AM
Innovate Marquette Smartzone hosts Women in Entrepreneurship eventInnovate Marquette Smartzone hosts Women in Entrepreneurship event
www.msn.com - January 18 at 9:01 AM
How a merger could mean the 'next Salix' for RaleighHow a merger could mean the 'next Salix' for Raleigh
finance.yahoo.com - November 18 at 2:21 PM
RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease PipelineRDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease Pipeline
finance.yahoo.com - November 13 at 9:32 AM
Innovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna KazanchyanInnovate Biopharmaceuticals Announces Appointment of Saira Ramasastry to Board of Directors and Resignation of Anna Kazanchyan
www.bloomberg.com - October 10 at 10:28 PM
BRIEF-Innovate Biopharmaceuticals To Acquire RDDBRIEF-Innovate Biopharmaceuticals To Acquire RDD
www.msn.com - October 8 at 12:11 AM
Triangle drugmaker plans merger with Israeli pharma -- what it means for RaleighTriangle drugmaker plans merger with Israeli pharma -- what it means for Raleigh
finance.yahoo.com - October 7 at 7:10 PM
Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac DiseaseInnovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac Disease
finance.yahoo.com - August 13 at 12:05 PM
Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesInnovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates
finance.yahoo.com - August 8 at 9:27 PM
Investors Who Bought Innovate Biopharmaceuticals (NASDAQ:INNT) Shares A Year Ago Are Now Down 82%Investors Who Bought Innovate Biopharmaceuticals (NASDAQ:INNT) Shares A Year Ago Are Now Down 82%
finance.yahoo.com - July 19 at 1:09 PM
Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseInnovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release
finance.yahoo.com - July 16 at 11:16 AM
Triangle pharma brings in new CFO looking for capitalTriangle pharma brings in new CFO looking for capital
finance.yahoo.com - June 25 at 8:16 AM
Triangle drugmaker launches historic trial for celiac diseaseTriangle drugmaker launches historic trial for celiac disease
finance.yahoo.com - June 11 at 11:51 AM
Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseInnovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease
finance.yahoo.com - June 10 at 12:02 PM
Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San DiegoInnovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Larazotide at the 2019 Digestive Disease Week Conference in San Diego
finance.yahoo.com - May 20 at 10:09 AM
Innovate Biopharma -3.8% on holders offering of 15.1M sharesInnovate Biopharma -3.8% on holders' offering of 15.1M shares
seekingalpha.com - May 18 at 8:49 AM
Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San DiegoInnovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego
finance.yahoo.com - May 9 at 11:34 AM
Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct OfferingInnovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering
finance.yahoo.com - May 2 at 11:37 AM
Edited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMTEdited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMT
finance.yahoo.com - May 1 at 11:13 AM
Rollercoaster ride for Innovate stock on Wall Street MondayRollercoaster ride for Innovate stock on Wall Street Monday
www.bizjournals.com - April 29 at 4:06 PM
Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q1 2019 Results - Earnings Call TranscriptInnovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - April 29 at 4:06 PM
Roller-coaster ride for Innovate's stock on Wall Street MondayRoller-coaster ride for Innovate's stock on Wall Street Monday
finance.yahoo.com - April 29 at 4:06 PM
Innovate Bio up 27% premarket on positive preclinical NASH dataInnovate Bio up 27% premarket on positive preclinical NASH data
seekingalpha.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of ActionInnovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action
www.nasdaq.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR agonist, and Reports key first quarter 2019 financial results and operational highlightsInnovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Intestinal Barrier, to Demonstrate Improvements in validated NASH Biomarkers and Endpoints in synergy with obeticholic acid, an FXR agonist, and Reports key first quarter 2019 financial results and operational highlights
finance.yahoo.com - April 29 at 11:16 AM
Innovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast DetailsInnovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast Details
finance.yahoo.com - April 26 at 4:09 PM
Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the LiverInnovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver
www.nasdaq.com - April 11 at 4:12 PM
Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Positive Effect of Larazotide on Reduced Intestinal Permeability in a NASH Preclinical StudyInnovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Positive Effect of Larazotide on Reduced Intestinal Permeability in a NASH Preclinical Study
finance.yahoo.com - April 11 at 4:12 PM
Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on April 29, 2019
finance.yahoo.com - April 2 at 11:14 AM
Innovate reiterates the start of the first Phase 3 clinical trial in celiac disease in Q2 2019Innovate reiterates the start of the first Phase 3 clinical trial in celiac disease in Q2 2019
www.globenewswire.com - March 26 at 12:01 PM
Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical ModelsInnovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical Models
finance.yahoo.com - March 26 at 12:01 PM
Innovate Biopharma raises more cash, chases treatment for celiac diseaseInnovate Biopharma raises more cash, chases treatment for celiac disease
finance.yahoo.com - March 20 at 4:25 PM
Innovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q4 2018 Results - Earnings Call TranscriptInnovate Biopharmaceuticals, Inc. (INNT) CEO Sandeep Laumas on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 19 at 4:23 PM
Why the FDA Commissioner Pushed To Shorten Medical Device Approval ProcessWhy the FDA Commissioner Pushed To Shorten Medical Device Approval Process
www.marketwatch.com - March 19 at 12:03 PM
Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019
finance.yahoo.com - March 19 at 12:03 PM
Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate HighlightsInnovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 2018 Earnings and Key Corporate Highlights
finance.yahoo.com - March 19 at 12:03 PM
Innovate Bio up 19% in capital raise to fund late-stage INN-202 studyInnovate Bio up 19% in capital raise to fund late-stage INN-202 study
seekingalpha.com - March 18 at 4:25 PM
Innovate Pharmaceuticals banks another $5.5 millionInnovate Pharmaceuticals banks another $5.5 million
www.bizjournals.com - March 18 at 4:25 PM
Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial - NasdaqInnovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial - Nasdaq
www.nasdaq.com - March 18 at 11:02 AM
Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical TrialInnovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial
finance.yahoo.com - March 18 at 11:02 AM
This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.